LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 88.84 | 27.76 | 1559 | 6965 | 0.2238 | 0.6576 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.55 | 27.76 | 4 | 6928 | 0.0006 | -0.2159 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.55 | 27.76 | 1109 | 6928 | 0.1601 | 0.5890 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.55 | 27.76 | 610 | 6928 | 0.0880 | 0.4740 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.55 | 27.76 | 1596 | 6928 | 0.2304 | 0.6633 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.25 | 27.76 | 7 | 6873 | 0.0010 | -0.1591 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.25 | 27.76 | 1106 | 6873 | 0.1609 | 0.5895 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.25 | 27.76 | 589 | 6873 | 0.0857 | 0.4684 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.25 | 27.76 | 1581 | 6873 | 0.2300 | 0.6625 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.96 | 27.76 | 6 | 6849 | 0.0009 | -0.1753 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.96 | 27.76 | 1136 | 6849 | 0.1659 | 0.5953 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.96 | 27.76 | 513 | 6849 | 0.0749 | 0.4434 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.96 | 27.76 | 1597 | 6849 | 0.2332 | 0.6652 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 95.66 | 27.76 | 7 | 6712 | 0.0010 | -0.1597 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 95.66 | 27.76 | 1125 | 6712 | 0.1676 | 0.5961 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 95.66 | 27.76 | 454 | 6712 | 0.0676 | 0.4233 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 95.66 | 27.76 | 1611 | 6712 | 0.2400 | 0.6701 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 1.95 | 27.76 | 432 | 225 | 1.9188 | 1.4817 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 1.95 | 27.76 | 3 | 225 | 0.0133 | -0.5213 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 1.95 | 27.76 | 661 | 225 | 2.9359 | 1.8571 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.66 | 27.76 | 462 | 283 | 1.6272 | 1.3124 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.66 | 27.76 | 708 | 283 | 2.4936 | 1.6262 | MN20160318_Q01 | K20 |